These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8268395)

  • 21. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents].
    Adams DR; Martul R; Alvarez MV; López Zumel MC; Espada M
    Acta Cient Venez; 1991; 42(5):257-65. PubMed ID: 1843567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromomisonidazole: synthesis and characterization of a new radiosensitizer.
    Rasey JS; Krohn KA; Freauff S
    Radiat Res; 1982 Sep; 91(3):542-54. PubMed ID: 7122830
    [No Abstract]   [Full Text] [Related]  

  • 23. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation Between Radiosensitizing Activity and the Stereo-structure of the TX-2036 Series of Molecules.
    Ohkura K; Tabata A; Uto Y; Hori H
    Anticancer Res; 2019 Aug; 39(8):4479-4483. PubMed ID: 31366548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging.
    Biskupiak JE; Grierson JR; Rasey JS; Martin GV; Krohn KA
    J Med Chem; 1991 Jul; 34(7):2165-8. PubMed ID: 2066990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the repair and damage of DNA induced by parent and reduced RSU-1069, a 2-nitroimidazole-aziridine.
    O'Neill P; Cunniffe SM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):963-6. PubMed ID: 2649467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
    Binger M; Workman P
    Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
    Kasai S; Nagasawa H; Yamashita M; Masui M; Kuwasaka H; Oshodani T; Uto Y; Inomata T; Oka S; Inayama S; Hori H
    Bioorg Med Chem; 2001 Feb; 9(2):453-64. PubMed ID: 11249137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
    Hei TK; Geard CR; Osmak RS; Hall EJ
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I; Stratford IJ; Jenkins TC
    Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG; Russo A; Gamson J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
    Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
    Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.
    Kumar P; Shustov G; Liang H; Khlebnikov V; Zheng W; Yang XH; Cheeseman C; Wiebe LI
    J Med Chem; 2012 Jul; 55(13):6033-46. PubMed ID: 22708968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
    Chaplin DJ; Durand RE; Stratford IJ; Jenkins TC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1091-5. PubMed ID: 3755714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
    Adams GE; Ahmed I; Sheldon PW; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
    Jenner TJ; Sapora O; O'Neill P; Fielden EM
    Biochem Pharmacol; 1988 Oct; 37(20):3837-42. PubMed ID: 3190731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study.
    Sansom GN; Kirk NS; Guise CP; Anderson RF; Smaill JB; Patterson AV; Kelso MJ
    Bioorg Med Chem Lett; 2019 May; 29(10):1215-1219. PubMed ID: 30885680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioreductive therapies: an overview of drugs and their mechanisms of action.
    Rauth AM; Melo T; Misra V
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):755-62. PubMed ID: 9845091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins.
    Naylor MA; Stephens MA; Cole S; Threadgill MD; Stratford IJ; O'Neill P; Fielden EM; Adams GE
    J Med Chem; 1990 Sep; 33(9):2508-13. PubMed ID: 2391690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.